NCT06769919View on ClinicalTrials.gov

A Randomized Controlled Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined with Systemic Therapy for Early-stage Breast Cancer

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

340

Participants

Timeline

Start Date

December 31, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2031

Conditions
Breast Cancer
Interventions
RADIATION

Neoadjuvant radiotherapy

The experimental group will receive neoadjuvant systemic therapy combined with neoadjuvant radiotherapy before undergoing surgery

Trial Locations (1)

710032

Xijing hospital, Xi'an

All Listed Sponsors
lead

Xijing Hospital

OTHER